Dongmei Wang
Executive Vice President
pharmaceutical
Frontage
China
Biography
Dr. Dongmei Wang is General Manager of Frontage’s CMC services group. With more than 20 years of pharmaceutical development experience, Dr. Wang’s CMC oversight spans organic synthesis, formulation development, GMP analytical testing, and GMP manufacturing of clinical trial materials. Prior to joining Frontage, Dr. Wang served as the Director of Analytical at NovaDel Pharma Inc., where she led teams in providing support for NDA product development, clinical supplies manufacturing, CMC sections of regulatory filings, and technology transfer to commercial manufacturing sites.
Research Interest
pharmaceutical
